Division of Infectious Diseases, Department of Internal Medicine, Seoul National University Bundang Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam, Gyeonggi-do, 13620, the Republic of Korea.
Department of Internal Medicine, Korea Veterans Hospital, Seoul, the Republic of Korea.
Eur J Clin Microbiol Infect Dis. 2022 Dec;41(12):1459-1465. doi: 10.1007/s10096-022-04508-2. Epub 2022 Oct 13.
This retrospective study aimed to clarify the interspecies differences in the clinical characteristics and risk factors of bloodstream infection (BSI) due to third-generation cephalosporin-resistant (3GC-R) Escherichia coli (EC) and Klebsiella pneumoniae (KP) in patients with liver cirrhosis (LC). KP BSI had more comorbidities and higher treatment failure rate than EC BSI. Non-alcoholic LC was a risk factor for treatment failure in EC, whereas it was not associated with KP. Risk factors for BSI due to 3GC-R strain were nosocomial infection in EC, and β-lactam/fluoroquinolone treatment ≤ 30 days in KP. These results could help predict outcomes of BSI and improve clinical practice.
本回顾性研究旨在阐明肝硬化患者中第三代头孢菌素耐药(3GC-R)大肠埃希菌(EC)和肺炎克雷伯菌(KP)血流感染(BSI)的临床特征和危险因素的种间差异。与 EC 相比,KP 引起的 BSI 合并症更多,治疗失败率更高。非酒精性 LC 是 EC 治疗失败的危险因素,而与 KP 无关。3GC-R 菌株引起的 BSI 的危险因素为 EC 的医院感染,以及 KP 的β-内酰胺/氟喹诺酮治疗≤30 天。这些结果有助于预测 BSI 的结果并改善临床实践。